Eledon Pharmaceuticals Inc. buy Guggenheim
Start price
28.01.25
/
50%
€4.54
Target price
28.01.26
€8.63
Performance (%)
-69.16%
Price
12.12.25
€1.41
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Eledon Pharmaceuticals Inc. is performing very badly with a performance of -69.16%. This prediction currently runs until 28.01.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eledon Pharmaceuticals Inc. | 6.015% | 6.015% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Guggenheim for this prediction
In the thread Eledon Pharmaceuticals Inc. diskutieren
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $9.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
Stopped prediction by Guggenheim for Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.34
18.11.25
18.11.25
€6.90
18.11.26
18.11.26
20.15%
12.12.25
12.12.25
